[go: up one dir, main page]

Follenius et al., 1991 - Google Patents

Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone

Follenius et al., 1991

View PDF
Document ID
4070826144164513362
Author
Follenius M
Krieger J
Krauth M
Sforza F
Brandenberger G
Publication year
Publication venue
Sleep

External Links

Snippet

To assess the effect of obstructive sleep apnea treatment on plasma renin activity (PRA) and plasma aldosterone seven male patients were studied under two conditions: untreated and treated with nasal continuous positive airways pressure (CPAP). PRA and plasma …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids

Similar Documents

Publication Publication Date Title
Follenius et al. Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone
Späth-Schwalbe et al. Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness
Späth-Schwalbe et al. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns
Thorell et al. Insulin resistance after abdominal surgery
Sullivan et al. Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose-mask
Baruzzi et al. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome
Pekkarinen et al. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors
US4725585A (en) Method of enhancing the host defense
Brandenberger et al. Nocturnal oscillations in plasma renin activity and REM-NREM sleep cycles in humans: a common regulatory mechanism?
Browne et al. The interdependence of gastric secretion and the CO2 content of the blood
WO1991004058A3 (en) Treatment of conditions and disease
WO1996040105A1 (en) Use of gamma-hydroxybutyrate for the stimulation of sleep-related growth hormone secretion
JP2007332163A (en) Method for treating obesity using prolactin modulator and diet
Lindgren et al. The effect of inhaled clonidine in patients with asthma
Goichot et al. Nocturnal plasma thyrotropin variations are related to slow‐wave sleep
Jönson et al. Vagal stimulation of duodenal HCO3‐secretion in anaesthetized rats
Alving et al. Capsaicin and histamine antagonist‐sensitive mechanisms in the immediate allergic reaction of pig airways
Spiegel et al. Prolactin secretion during sleep in obstructive sleep apnoea patients
Cahan et al. Erythropoietin levels with treatment of obstructive sleep apnea
Äärimaa et al. Glucose tolerance and insulin response during and after elective skeletal surgery
Ueno et al. Prostaglandin D2 regulates physiological sleep
Aubert-Tulkens et al. Cure of sleep apnea syndrome after long-term nasal continuous positive airway pressure therapy and weight loss
Brandenberger et al. Renin as a biological marker of the NREM‐REM sleep cycle: effect of REM sleep suppression
Naesh et al. Epidural anaesthesia prolonged into the postoperative period prevents stress response and platelet hyperaggregability after peripheral vascular surgery
Silverberg et al. Sleep-related breathing disturbances: their pathogenesis and potential interest to the nephrologist.